New brands push up Beiersdorf's medical sales:
This article was originally published in Clinica
Executive Summary
The medical division of German company Beiersdorf recorded growth of 18.7% in the first quarter of 1996, largely due to the acquisition of the Futuro and Curad brands in January (see Clinica No 687, p 11). The company reported overall turnover of DM 1,486 million ($990 million), an increase of 7.6% on the same period in the previous year.